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Abstract
Pandemic H1N1/2009 influenza virus, derived from a reassortment of avian, human, and swine influenza viruses, possesses a
unique gene segment combination that had not been detected previously in animal and human populations. Whether such
a gene combination could result in the pathogenicity and transmission as H1N1/2009 virus remains unclear. In the present
study, we used reverse genetics to construct a reassortant virus (rH1N1) with the same gene combination as H1N1/2009
virus (NA and M genes from a Eurasian avian-like H1N1 swine virus and another six genes from a North American triple-
reassortant H1N2 swine virus). Characterization of rH1N1 in mice showed that this virus had higher replicability and
pathogenicity than those of the seasonal human H1N1 and Eurasian avian-like swine H1N1 viruses, but was similar to the
H1N1/2009 and triple-reassortant H1N2 viruses. Experiments performed on guinea pigs showed that rH1N1 was not
transmissible, whereas pandemic H1N1/2009 displayed efficient transmissibility. To further determine which gene segment
played a key role in transmissibility, we constructed a series of reassortants derived from rH1N1 and H1N1/2009 viruses.
Direct contact transmission studies demonstrated that the HA and NS genes contributed to the transmission of H1N1/2009
virus. Second, the HA gene of H1N1/2009 virus, when combined with the H1N1/2009 NA gene, conferred efficient contact
transmission among guinea pigs. The present results reveal that not only gene segment reassortment but also amino acid
mutation were needed for the generation of the pandemic influenza virus.
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Introduction
Pandemic H1N1/2009 influenza virus spread by human-to-
human transmission across the globe at an unprecedented rate
after it was first detected in humans [1,2]. By August 2010, H1N1/
2009 virus had spread to more than 215 countries with over
18,000 deaths reported worldwide [3]. The H1N1 influenza virus
is now considered to be post-pandemic, yet it is feared that it could
still pose a public health threat, especially if it recombines with
other influenza viruses, yielding a novel potential pandemic strain
[4,5]. Therefore, the incidence of pandemic H1N1/2009
reiterated the importance of elucidating the genesis of novel
emerging pathogens for its prevention and control.
Genetic analyses revealed that the pandemic H1N1/2009
influenza viruses possessed a unique combination of gene segments
from swine, human and avian origins; containing PB2 and PA
genes of North American avian virus origin, the PB1 gene of
human H3N2 virus origin, HA, NP and NS genes of classical
swine H1N1 virus origin, and NA and M genes of Eurasian avian-
like swine virus origin [6,7]. These genes have been already
established in the triple-reassortant H1N2 and H1N1 swine viruses
in North America and in the Eurasian avian-like swine H1N1
viruses for more than 10 years [8–11]. Thus, H1N1/2009 was
probably a result of an immediate reassortment between two or
more swine viruses, i.e. triple-reassortant H1N2 (or H1N1) and the
Eurasian avian-like H1N1 swine viruses [7,12–14].
Although the genome of H1N1/2009 virus was described
putatively to be of swine origin, a virus with the same gene
combination as H1N1/2009 virus has not been reported in swine
or other hosts [1,15] because of poor surveillance of swine
influenza viruses worldwide [6]. However, evolutionary analysis
indicated that the reassortment between North American and
Eurasian swine viruses may not have occurred recently, and it is
possible that reassortant virus of this gene combination has been
cryptically circulating for years before outbreak in humans [15].
Hence, the virus might have experienced two steps: 1) gene
segment reassortment; 2) mutual variation of the eight gene
segments under unspecified conditions. The following questions
remain: (i) what are the biological characteristics of a virus with the
same gene combination as H1N1/2009 virus, and (ii) which gene
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virus and H1N1/2009 virus?
In the present study, we used reverse genetics to generate a
reassortant virus (rH1N1) with the same gene combination H1N1/
2009 virus, in which NA and M gene segments were from a
Eurasian avian-like H1N1 swine influenza virus and the other six
genes were from a triple-reassortant H1N2 swine influenza virus.
The rH1N1 virus was characterized in vitro and in vivo and
compared with pandemic H1N1/2009 virus, a North American
triple-reassortant swine H1N2 virus, a Eurasian avian-like swine
virus, and a seasonal human H1N1 virus. Moreover, the gene
segments responsible for the difference of transmissibility between
rH1N1 and H1N1/2009 viruses were investigated.
Results
Generation and in vitro characteristics of rH1N1 virus
Our previous study found that the NA and M genes of a
Eurasian avian-like H1N1 swine influenza virus, A/swine/Fujian/
204/2007 (Eurasian-204, accession numbers: FJ536810-FJ536817)
[16] and the other six genes of a triple-reassortant H1N2 swine
influenza virus A/swine/Guangdong/1222/2006 (Triple-1222,
accession numbers: GU086078-GU086085) [8] belonged to the
same cluster of H1N1/2009 viruses in the phylogenetic tree. Here,
using reverse genetics, we generated the reassortant virus rH1N1
possessing the same gene combination as H1N1/2009 virus with
NA and M gene segments from the Eurasian-204 virus, and the
other six genes from the Triple-1222 virus. The sequence
homology between the rH1N1 and H1N1/2009 influenza strains
are shown in Table 1.
The replication of rH1N1 virus in MDCK cells was tested and
compared with those of pBJ09 (accession numbers: HQ533879,
HQ533877, HQ533874, HQ533864, HQ533871, HQ533868,
HQ533866, and HQ533872), Triple-1222, Eurasian-204, and A/
Tianjin/15/2009 (accession numbers: HQ533878, HQ533876,
HQ533875, HQ533865, HQ533870, HQ533869, HQ533867,
and HQ533873) viruses. MDCK cells were inoculated with each
H1 virus at an MOI of 0.05, and the supernatant was titrated at
12, 24, 36, 48, 60, and 72 h p.i. As shown in Fig. 1, there were no
significant differences in the viral yields between rH1N1 and
pBJ09 viruses (P.0.05), except for the titers at 24 h p.i., wherein
rH1N1 virus had lower viral yields when compared with pBJ09
virus at each time point (P,0.01). Eurasian-204 and hTJ15 viruses
replicated with lower titers than pBJ09 virus during the observed
period (P,0.01).
Infectivity and pathogenicity of rH1N1 virus in mice
rH1N1, pBJ09, Triple-1222, Eurasian-204, and hTJ15 viruses
were intranasally inoculated in mice, respectively. Clinical signs,
MID50,L D 50, virus replication, and tissue distribution in mice were
examined. As shown in Fig. 2, rH1N1, pBJ09, and Triple-1222
viruses causedsustained weight loss andcould cause mice dead. The
bodyweightofthe miceinfected byEurasian-204andhTJ15viruses
increased after slight weight loss and were significantly higher than
those of rH1N1, pBJ09, and Triple-1222 viruses since day 5 p.i.
(P,0.05), and these mice were with 100% survival rates. Moreover,
obvious clinical signs of disease were observed in mice infected by
rH1N1, pBJ09, and Triple-1222 viruses, including decreased
activity, huddling, hunched posture, and ruffled fur, while mice
infected with Eurasian-204 and hTJ15 viruses did not display
obvious clinical signs during the course of the experiment. The
rH1N1 (MID50=10
0.5 PFU), pBJ09 (MID50=10
0.6 PFU), and
Triple-1222 (MID50=10
0.3 PFU) viruses were more infectious in
mice than the Eurasian-204 (MID50=10
1.5 PFU) and hTJ05
(MID50=10
1.0 PFU) viruses. The rH1N1 (LD50=10
3.0 PFU),
pBJ09 (LD50=10
3.6 PFU), and Triple-1222 (LD50=10
3.5 PFU)
viruses were also more virulent than Eurasian-204
(LD50.10
6.0 PFU) and hTJ05 (LD50.10
6.0 PFU) viruses.
The viral distribution in nasal turbinates, trachea, lung, liver,
spleen, kidney, and brain of mice were investigated. Apart from
the nasal turbinates, trachea and lung, the presence of virus was
not detected in the other tissues, revealing that all these viruses
were restricted to the respiratory system of mice. In the nasal
turbinates, rH1N1 virus replicated with significantly lower titers
than pBJ09 virus (P,0.01) (Fig. 3A). As shown in Fig. 3B and C, the
titers of rH1N1, pBJ09, and Triple-1222 viruses were higher than
those of Eurasian-204 and hTJ15 viruses in trachea and lung on
days 3, 5, and 7 p.i. (P,0.05) (except for hTJ15 in trachea on day
3 p.i. and Eurasian-204 in lung on day 5 p.i.).
Taken together, these results indicated that rH1N1 virus had similar
infectivity and pathogenicity to that of pandemic H1N1/2009 and
triple-reassortant viruses, while it had higher pathogenicity than the
seasonal human H1N1 and Eurasian avian-like H1N1 viruses.
Table 1. Gene homology of the rH1N1 vs. H1N1/2009 influenza virusesa
a.
Virus Subtype Lineage Gene segment
PB2 PB1 PA HA NP NA M NS
A/Mexico/4115/2009 H1N1 H1N1/2009 95.2 95.2 94.6 94.1 95.5 90.9 95.4 93.7
A/California/04/2009 H1N1 H1N1/2009 95.2 95.1 94.6 93.9 95.5 90.8 95.4 93.7
A/Beijing/7/2009 (pBJ09) H1N1 H1N1/2009 95.0 95.0 94.5 93.8 95.4 90.7 95.6 93.3
aComparison of the full-length gene sequences.
doi:10.1371/journal.pone.0022091.t001
Figure 1. Viral growth kinetics in MDCK cells. MDCK cells were
infected with virus at a MOI of 0.05, supernatants were harvested every
12 h, and samples were titrated by plaque assay in MDCK cells. Results
represent the average of three independent experiments.
doi:10.1371/journal.pone.0022091.g001
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virus in mice
To evaluate the histopathological changes between rH1N1 and
other H1 viruses in mice, nasal turbinate, trachea, and lung samples
from infected mice were fixed in 10% neutral buffered formalin and
processed for routine histology. Representative histopathological
changes are shown in Fig. 4. Lungs of all mice infected with viruses
showed varying degrees of pneumonia. The histopathological
changes in mice infected with rH1N1, pBJ09 and Triple-1222
viruses were more severe than those of other viruses. Severe
bronchiolitis, peribronchiolitis, and bronchopneumonia were ob-
served in mice infected with rH1N1, pBJ09, and Triple-1222
viruses. These changes were characterized by dropout and necrosis
of mucous epithelium cells in the bronchioles, inflammatory cell
infiltration near the small blood vessels, interstitial edema and
thickening of the alveolar walls, and alveolar lumen flooded with
dropout of alveolar cell, erythrocytes and inflammatory cells.
Tunica mucosa tracheae and tunica mucosa nasi were severely
damaged and a number of mucous epithelial cell exfoliates were
found in the tracheal and nasal cavities. The Eurasian-204- and
hTJ15-infected groups showed mild pathological lesions, which
was characterized by inflammatory cell infiltration around the
bronchioles and small blood vessels in lung, while no apparent
histological changes were observed in the trachea and nasal turbinates.
Immunohistochemistry showed that viral antigen was distribut-
ed in deciduous alveolar cells, macrophages, infiltrative lympho-
cytes, lung bronchiolar epithelium cells, deciduous epithelial cells,
tracheal infiltrative inflammatory cells, deciduous epithelium cells,
and infiltrative inflammatory cells in nasal cavity of rH1N1, pBJ09
and Triple-1222 infected mice (Fig. S1). In the Eurasian-204 and
Figure 2. Weight change (A) and survival (B) of mice. Groups of four BALB/c mice were intranasally inoculated with 10
4.0 PFU of each virus.
Body weight and survival status were checked daily. Mice were euthanized upon the loss of 30% of their initial body weight.
doi:10.1371/journal.pone.0022091.g002
Figure 3. Viral replication in nasal turbinates (A), trachea (B) and lung (C) of mice. Groups of three BALB/c mice were intranasally inoculated
with 10
4.0 PFU of each virus. Titers of virus recovered from the supernatant of homogenized nasal turbinates, trachea and lung on days 3, 5 and 7 p.i.
are shown. Results represent the average titers from the tissues of three infected mice per group. The limit of virus detection was 100 PFU/g. ** in Fig.
3A indicates the significant difference between rH1N1 and pBJ09 viruses (P,0.01; ANOVA). * and ** in Fig. 3B and C indicates the replication titers of
Eurasian-204 or hTJ15 are significantly different from those of rH1N1, pBJ09 and Triple-1222 viruses (* is with P,0.05, ** is with P,0.01; ANOVA).
doi:10.1371/journal.pone.0022091.g003
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22091Figure 4. Histopathological changes in H1 virus-infected mice. Photomicrographs of H&E stained sections from nasal turbinates, trachea and
lungs of mice on day 7 p.i. are shown. (A) rH1N1 virus-infected lung. Observation of extensive dropout and necrosis of mucous epithelium cells
(open arrows), inflammatory cell infiltration and thickening of alveolar walls (solid arrows). (B) pBJ09 virus-infected lung. Dropout of mucous
epithelium (open arrows), interstitial edema near the small blood vessels (solid arrows). (C) Triple-1222 virus-infected lung. Inflammatory cells
infiltrate near the blood vessels (solid arrows) and dropout of mucous epithelium cells (open arrows). (D) Eurasian-204 virus-infected lung. Few
inflammatory cells infiltrated near the bronchiole and blood vessels (solid arrows). (E) hTJ15 virus-infected lung. Few inflammatory cell infiltrated
near the bronchiole and blood vessels (solid arrows). (F) rH1N1 virus-infected trachea. Dropout of mucous epithelium and inflammatory cell
infiltration (solid arrows). (G) pBJ09 virus-infected trachea. Severe dropout of mucous epithelium cells in trachea, lamina propria bareness (solid
arrows). (H) Triple-1222 virus-infected trachea. Dropout of mucous epithelium cells and many erythrocytes (solid arrows). Eurasian-204 virus-
infected trachea (I) and hTJ15 virus-infected trachea (J). Rare histopathologic lesion. (K) rH1N1 virus-infected nasal turbinate. Dropout
of mucous epithelium cells (solid arrows). (L) pBJ09 virus-infected nasal turbinate. Extensive dropout of mucous epithelium cells in nasal
Artificial Swine-Origin Influenza Virus
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alveolar cells and mucosal epithelium cells in lung, but were rarely
found in trachea and mucosal lamina propria cells of nasal
turbinates.
In general, more severe histopathological changes were observed
in the respiratory tract of mice infected with rH1N1, H1N1/2009,
and triple-reassortant swine viruses than those infected with
Eurasian avian-like and seasonal human influenza viruses.
Transmissibility of rH1N1 virus in a guinea pig model
Efficient transmissibility is a typical feature of pandemic H1N1/
2009 virus. To determine whether rH1N1 virus possesses this
property, we evaluated the contact transmissibility of rH1N1 virus
in guinea pigs. Simultaneously, H1N1/2009, triple-reassortant
swine, Eurasian avian-like swine, and seasonal human influenza
viruses were also evaluated for their transmissibility in guinea pigs.
Transmission was determined by the detection of virus in the nasal
washes and seroconversion. The animal experiments showed that
no obvious clinical signs were observed in any of the guinea pigs
including inoculated and un-inoculated animals during the
observation period. All the tested viruses were able to replicate
in the nasal passages of inoculated animals, with peak titers from
4.7–6.5 log10 PFU/mL. As shown in Fig. 5, no virus shedding or
seroconversion was detected in any exposed animals of rH1N1
groups, as well as Triple-1222 and Eurasian-204 groups. By
contrast, pBJ09 virus showed efficient transmission that all four
exposed animals were detected to be positive, while hTJ15
transmitted less efficiently than pBJ09 with two of four exposed
animal becoming infected. These results indicated that although
rH1N1 virus has a pathogenicity that is similar to H1N1/2009
virus in mice, it does not acquire the transmissibility in guinea pigs
which is a typical trait of H1N1/2009 virus.
Identification of the gene segment contributing to the
different transmissibility between rH1N1 and H1N1/2009
viruses
To determine which gene segment contributes to the transmis-
sion difference between rH1N1 and pBJ09 viruses, reverse genetics
was used to construct a series of viruses with the gene segments
from rH1N1 and pBJ09 viruses and their transmissibility were
tested in guinea pigs. Two strategies of virus constructing were
approached. First, to determine whether the surface genes or the
internal genes contribute to the different transmissibility between
rH1N1 and pBJ09 viruses, two reassortants were constructed by
introducing two surface genes and six internal genes from pBJ09 in
the rH1N1 backbone, respectively. As shown in Table 2, the novel
Figure 5. Contact transmission of rH1N1 (A), pBJ09 (B), Triple-1222 (C), Eurasian-204 (D) and hTJ15 (E) viruses in guinea pigs. Four
guinea pigs were intranasally inoculated with 10
4.0 PFU of virus and each animal was housed in a separate cage. At 24 h p.i., a naı ¨ve guinea pig was
placed in the same cage with each inoculated guinea pig. Virus titers in nasal washes were plotted as a function of time post-inoculation. Titers of
intranasally inoculated animals are represented by dashed lines and solid squares; virus titers of exposed guinea pigs are shown with solid lines and
solid triangles. The limit of virus detection was 10 PFU/mL.
doi:10.1371/journal.pone.0022091.g005
turbinates (solid arrows). (M) Triple-1222 virus-infected nasal turbinate. Lesional tunica mucosa nasi (solid arrows). Eurasian-204 virus
infected nasal turbinates (N) and hTJ15 virus-infected nasal turbinates (O). No apparent histopathologic lesion. Bar=50 mm.
doi:10.1371/journal.pone.0022091.g004
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among guinea pigs as pBJ09 virus, with 100% efficiency; while the
rH1N1HANA:pBJ09 virus transmitted inefficiently, with only one
of four exposed animals becoming infected. The results indicated
that the surface genes of pBJ09 played an important role in
efficient transmissibility and that the internal genes were also
involved in the transmission. To further identify which single gene
was related to the transmissibility, a series of reassortants with
individual genes from pBJ09 using the rH1N1 backbone were
rescued and their transmissibility were investigated in guinea pigs.
The transmission experiments showed that only the reassortants
with HA or NS genes replaced by that of pBJ09 in the backbone of
rH1N1 could transmit between guinea pigs, but the respective
transmission efficiency was lower than that of pBJ09 virus
(Table 2). The pBJ09HA: rH1N1 virus transmitted to three of
four exposed animals, while pBJ09NS: rH1N1 virus transmitted to
two of four exposed animals. It is noteworthy that pBJ09HA:
rH1N1 virus replicated less efficiently in the nasal wash than those
of pBJ09 and rH1N1 viruses. However, the replication ability was
increased by the introduction of both HA and NA genes from
pBJ09 in the rH1N1 backbone (P,0.01). Collectively, the present
findings demonstrated that the HA and NS genes of H1N1/2009
virus contribute to viral transmissibility, but are not sufficient for
efficient transmission. The HA gene of H1N1/2009 virus, when
combined with H1N1/2009 NA, confers efficient contact
transmission in guinea pigs.
Comparison of the amino acid of HA and NS proteins
between rH1N1 and pBJ09 viruses
The above data proved that the HA and NS genes contributed to
the H1N1/2009 viral transmissibility. To further determine the
molecular basis of the transmissibility, we compared the deduced
amino acid sequences of the HA and NS proteins between rH1N1
and pBJ09 viruses. The comparison of amino acid sequences showed
that there were a total of 25 amino acids in HA protein, 20 amino
acids in NS1 protein, and 8 amino acids in NS2 protein differences
between rH1N1 and pBJ09 viruses, suggesting that these amino acids
might play an important role in the transmissibility (Table 3, Table
S1, Table S2). Receptor binding specificity plays an important role in
the transmission of influenza virus [17]. It is noteworthy that four
amino acid sites, D135M, R136K, T219I, and A227E, located in the
HA receptor binding site, might partially contribute to the different
transmission of these two virus in guinea pigs.
Discussion
The historic 1957 and 1968 pandemic influenza viruses were
considered to be reassortant viruses that originated from avian and
human influenza viruses [18–20]. The current 2009 pandemic
virus, a swine-origin H1N1 influenza virus, was a more
complicated reassortant derivative of avian, swine, and human
viruses [6,7]. Although pandemic influenza viruses are usually
generated through reassortment, it is not clear whether the basic
reassortment without amino acid mutation of viral genome could
result in the emergence of a pandemic virus. In the present study,
we artificially engineered a reassortant influenza virus (rH1N1)
with the same genotype as H1N1/2009 virus by reverse genetics
and evaluated the pathogenicity in mice and transmissibility in
guinea pigs. Our results showed that the pathogenicity of rH1N1
virus in mice was similar to that of H1N1/2009 virus, while
rH1N1 virus did not possess the transmissibility among guinea pigs
as H1N1/2009 virus. Furthermore, we demonstrated that HA and
NS genes were crucial for transmissibility of H1N1/2009 virus,
and the HA gene combining with the H1N1/2009 NA confers
efficient transmission.
Previous studies showed that H1N1/2009 viruses replicated
efficiently and caused more severe pathological lesions in mice,
ferrets, and non-human primates than the circulating seasonal
human H1N1 [13]. Although rH1N1 was a reassortant derived
from the triple-reassortant H1N2 and Eurasian avian-like swine
H1N1 viruses, its characteristics in vitro and in vivo were similar to
those of the triple-reassortant, while being significantly different
from Eurasian avian-like. The current study performed in mice
indicated that rH1N1, pBJ09, and Triple-1222 viruses induced
more severe clinical signs, and replicated more efficiently in the
trachea and lung of mice than Eurasian swine and seasonal human
viruses. rH1N1, pBJ09, and Triple-1222 viruses induced higher
Table 2. Direct contact transmission of wild-type and rH1N1-pBJ09 reassortant viruses in guinea pigs.
Inoculated animals Contact animals
Virus
No. with virus
detection (peak titer)
a
No. with seroconversion
(HI titer range)
b
No. with virus
detection (peak titer)
a
No. with seroconversion
(HI titer range)
b Transmission
pBJ09 4/4 (6.560.4) 4/4 (320) 4/4 (5.560.3) 4/4 (160–320) Efficient
rH1N1 4/4 (4.760.4) 4/4 (40–80) 0/4 0/4 None
pBJ09HANA:rH1N1 4/4 (5.960.6) 4/4 (160–320) 4/4 (5.860.8) 4/4 (80–320) Efficient
rH1N1HANA:pBJ09 4/4 (5.360.2) 4/4 (80–160) 1/4 (3.1) 1/4 (40) Inefficient
pBJ09HA: rH1N1 4/4 (4.460.4) 4/4 (80–160) 3/4 (3.860.7) 3/4 (40–80) Inefficient
pBJ09NA: rH1N1 4/4 (5.060.3) 4/4 (80) 0/4 0/4 None
pBJ09PB2: rH1N1 4/4 (4.060.3) 4/4 (40–80) 0/4 0/4 None
pBJ09PB1: rH1N1 4/4 (4.860.4) 4/4 (80) 0/4 0/4 None
pBJ09PA:rH1N1 4/4 (5.060.5) 4/4 (80) 0/4 0/4 None
pBJ09NP: rH1N1 4/4 (4.460.2) 4/4 (40) 0/4 0/4 None
pBJ09M: rH1N1 4/4 (5.360.5) 4/4 (40–80) 0/4 0/4 None
pBJ09NS: rH1N1 4/4 (6.060.6) 4/4 (40–80) 2/4 (4.660.2) 2/4 (40–80) Inefficient
aNumber of the infected guinea pigs/total number of the guinea pigs (mean peak titer log10PFU/mL 6 standard deviation).
bSerum was collected on day 18 p.i. and seroconversion was confirmed by hemagglutination inhibition (HI) assay.
doi:10.1371/journal.pone.0022091.t002
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respiratory system than other viruses. The high pathogenicity of
Triple-1222 virus was consistent with the results of triple-
reassortant H1N1 swine influenza isolated in humans [21].
However, the pathogenicity of pBJ09 (LD50=10
3.6 PFU) was
higher than those of H1N1/2009 influenza viruses
(LD50$10
6.0 PFU), which were avirulent in mice in previous
studies [13,21–23]; except for the WSLH34936 virus
(LD50=10
4.5 PFU) [13]. The present results indicated that the
low pathogenicity observed in mice was not a common feature of
H1N1/2009 viruses, and that the pathogenicity of rH1N1 virus
was similar to (or higher than) that of H1N1/2009 virus.
Comparing the amino acid sequences of pBJ09 virus with those
of H1N1/2009, several genetic differences were found between
pBJ09 virus and the previously isolated strains. pBJ09 virus shared
some mutations in common with the pandemic variants that were
predominant in the southern hemisphere in the winter of 2010,
such as PB2 K660R, PB1 T257A, HA E391K, and NS1 M93I
mutations [24]. However, it remains unknown whether these
genetic changes contribute to the higher virulence and so need
further investigation.
H1N1/2009 influenza virus efficiently transmitted in humans.
Transmission animal models, including guinea pigs, pigs, and
ferrets, have been established [13,25–27]. Our guinea pig model
experiments indicated that H1N1/2009 virus had efficient
transmissibility among guinea pigs via a direct contact route.
However, like Triple-1222 and Eurasian-204 swine viruses,
rH1N1 virus did not transmitted in this animal model. To
investigate which gene segment contributed to the different
transmissibility between rH1N1 and pandemic H1N1/2009
viruses, we constructed a series of reassortants of these viruses
and evaluated their transmissibility. The results showed that
rH1N1 virus was transmissible among guinea pigs after acquiring
the HA or NS gene from H1N1/2009 virus. The role of the HA
gene in transmission has been previously demonstrated [28–31].
We also found that introduction of single HA gene from H1N1/
2009 virus resulted in inefficient replication and transmission of
reassortant in guinea pigs. By contrast, the H1N1/2009 HA gene
when combined with the H1N1/2009 NA gene conferred both
efficient replication and contact transmission between guinea pigs.
These results suggest that the interaction of HA and NA genes of
H1N1/2009 virus affected viral replication and transmission. The
NS gene has been demonstrated to be relevant to viral replication
and pathogenicity [32–34]. In the present study, the replication of
the rH1N1 virus in the nasal cavity of guinea pigs increased
significantly after the replacement of the NS gene by those of
H1N1/2009 (P,0.01), which is a plausible in terms of the
transmissibility of the pBJ09NS:rH1N1 virus among guinea pigs.
However, some reassortants with high titers were unable to
transmit among guinea pigs. Additionally, viruses (pBJ09 and
pBJ09HANA:rH1N1) which can efficient transmit among guinea
pigs had high peak virus titers in the inoculated animals.
Howerver, pBJ09NS:rH1N1 with comparable peak virus titers to
pBJ09HANA:rH1N1 (P.0.05) transmitted inefficient among
guinea pigs. These results indicated that high virus load of
inoculated animal might played an important role in the
transmission, but other factor(s) also contribute to the transmis-
sibility of influenza viruses. Further molecular analysis of HA,
NS1, and NS2 proteins showed that total of 53 amino acid
differences between rH1N1 and pBJ09 might be involved in the
transmissibility difference. The affinity of the viral HA protein for
sialic acid a-2,6 linked glycan confers transmission of the 1918
H1N1 influenza virus in ferrets (40). Four amino acid differences
(D135M, R136K, T219I and A227E) occurred in the HA receptor
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transmissibility. Recently, Haan et al reported that only two
residues (A200T and A227E) were responsible for the dramatic
receptor binding change from swine to pandemic H1 hemagglu-
tinin [35]. rH1N1 possessed 227A on HA protein, while pBJ09
had 227E. Further study is warranted to determine whether this
substitution contributed to the different transmissibility between
rH1N1 and pBJ09 viruses. Nevertheless, these results demonstrat-
ed that the reassortment between triple-reassortant and Eurasian
avian-like swine viruses is not sufficient for transmissibility as
H1N1/2009 virus, and further mutations may be necessary.
In summary, we demonstrated that infectivity, replication, and
pathogenicity of rH1N1, a virus with same gene combination as
H1N1/2009 virus, are similar to those of the pBJ09 (H1N1/2009)
virus. However, transmissibility in guinea pigs of rH1N1 virus was
not found. Moreover, we also demonstrated that the HA and NS
genes contributed to the transmission of H1N1/2009 virus; and
HA gene of H1N1/2009 virus, when combined with the H1N1/
2009 NA gene, conferred efficient contact transmission among
guinea pigs. The present findings demonstrated that a virus with
the same gene combination as H1N1/2009 virus did not directly
acquire the transmission phenotype as H1N1/2009 virus,
indicating that additional variation was needed for the efficient
transmissibility.
Materials and methods
Ethics statement
All animal research was approved by the Beijing Association for
Science and Technology, the approve ID is SYXK (Beijing) 2007-
0023, and complied with the guidelines of Beijing laboratory
animal welfare and ethical of Beijing Administration Committee of
Laboratory Animals.
Viruses
The North American triple-reassortant swine H1N2 influenza
virus, A/swine/Guangdong/1222/2006 (Triple-1222), was origi-
nally isolated from diseased pigs in 10-day old embryonated
chicken eggs and passaged twice in MDCK cells [8]. Eurasian
avian-like H1N1 swine virus, A/swine/Fujian/204/2007 (Eur-
asian-204), was isolated from healthy pigs in 10-day old
embryonated chicken eggs and passaged twice in MDCK cells
[16]. The pandemic H1N1/2009 influenza virus, A/Beijing/7/
2009 (pBJ09), was isolated from a young patient with an influenza-
like illness in December 2009 in 10-day old embryonated chicken
eggs and passaged once in MDCK cells. Seasonal human H1N1
influenza virus A/Tianjin/15/2009 (hTJ15) was kindly provided
by the Chinese Centers for Disease Control (CDC).
Generation of reassortant viruses by reverse genetics
Reverse transcription-PCR (RT-PCR) amplicons of the viral genes
were cloned into a dual-promoter plasmid, PHW2000. MDCK and
293T cells were co-cultured and transfected with 0.5 mgo fe a c ho ft h e
eight plasmids and 10 mL lipofectamine 2000 (Invitrogen) in a total
volume of 1 mL of Opti-MEM (Invitrogen). After incubation at 37
uC for 6 h, the transfection mixture was removed from the cells and
2 mL of Opti-MEM containing 1 mg/mL of TPCK-trypsin was
added. After 72 h, the supernatant was inoculated in MDCK cells to
producestockviruses.ViralRNAwasextractedandanalyzedbyRT-
PCR, and each viral segment was sequenced to confirm the identity
of the virus. The titers of the stock viruses were determined by plaque
assay on MDCK cells. All experiments with live viruses and
transfectants generated by reverse genetics were performed in a
biosafety level 3 containment laboratory approved by Ministry of
Agriculture of the People’s Republic of China and the approve ID is
CNAS BL0017.
Viral growth kinetics
MDCK cells were infected with each virus at a multiplicity of
infection (MOI) of 0.05, overlaid with serum-free Dulbecco’s
Modified Eagle Medium (DMEM) (Gibco, USA) containing
2.5 mg/mL N-acetyl-trypsin (Sigma–Aldrich, USA) and incubated
at 37uC. Cell supernatants were harvested every 12 h until 72 h
post-infection (p.i.), and titrated by plaque assays.
Viral pathogenicity in mice
Six-week-old female BALB/c mice (Vital River Laboratories
[VRL], China) were anaesthetized with Zoletil (tiletamine-
zolazepam; Virbac S.A., Carros, France; 20 mg/g) and intranasally
inoculated with 50 mL of infectious virus diluted in sterile
phosphate-buffered saline (PBS). The 50% mouse infectious dose
(MID50) and 50% lethal dose (LD50) were determined as
previously described [36,37]. Briefly, mice were euthanized on
day 3 p.i., and homogenized lung tissues were obtained to
determine the MID50 calculated by the method of Reed and
Muench [38]. Four mice per virus were monitored daily for 14
days p.i. for morbidity as measured by weight loss, and mortality to
determine the LD50. Any mouse that lost .30% of its pre-
inoculation body weight was euthanized. Three mice inoculated
with 10
4.0 plaque forming units (PFU) of each virus were
euthanized on days 3, 5 and 7 p.i. and the nasal turbinates,
trachea, lung, liver, spleen, kidney and brain were collected for
virus detection and titration.
Histopathology and immunohistochemistry (IHC) in mice
A portion of the nasal turbinates, trachea and lung of
euthanized mice were preserved in 10% phosphate-buffered
formalin on day 7 p.i. Samples were then processed for paraffin
embedding and cut into 5-mm thick sections. One section from
each tissue sample was stained with hematoxylin and eosin (H&E)
stain. Another section was processed for immunohistological
staining with a mouse monoclonal antibody (AA5H, Abcam,
Hong Kong) specifically against influenza A virus NP and a goat-
anti-mouse IgG biotin conjugated affinity purified antibody
(Chemicon, USA). Specific antigen–antibody reactions, substrate
and chromogen were visualized by brown staining using
diaminobenzidine-tetrahydrochloride (DAB) (Sigma, USA), then
hematoxylin was used as a counterstain.
Contact transmission in guinea pigs
Hartley strain female SPF/VAF guinea pigs weighing between
300–350 g, which were seronegative for influenza virus were
obtained from Vital River Laboratories (VRL) in China. Guinea
pigs were anesthetized by intramuscular injection of Zoletil 100
(tiletamine-zolazepam; Virbac, France; 10–15 mg/kg) prior to all
procedures including inoculation, nasal wash collection, collection
of blood). Four guinea pigs were inoculated intranasally with
10
4.0 PFU tested virus in 300 mL PBS. Each infected animal was
placed in the same cage with one naı ¨ve guinea pig at 24 h p.i..
Nasal washes were collected from all eight guinea pigs on days 2,
4, 6 and 8 p.i.
Statistical analyses
Statistically significant differences between experimental
groups were determined using of the analysis of variance
(ANOVA) method. A P-value ,0.05 was considered statistically
significant.
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Figure S1 Immunohistochemical analysis of virus-in-
fected mice. Tissue sections of the nasal turbinates trachea and
lungs were stained with a monoclonal antibody against influenza A
virus Nucleoprotein (AA5H); made visible by brown staining. Data
taken on day 7 p.i.. (A) rH1N1 virus-infected lung. Viral
antigen staining in alveolar cells and lymphocyte in the lung
(arrows). (B) pBJ09 virus-infected lung. Infected bronchiolar
mucosal epithelium cells in the lung (arrows). (C) Triple-1222
virus-infected lung. Infected deciduous mucosal epithelium
cells in the lungs (arrows). (D) Eurasian-204 virus-infected
lung. Rare virus-infected deciduous alveolar cells (arrows). (E)
hTJ15 virus-infected lung. Infected alveolar cells in the lungs
(arrows). (F) rH1N1 virus-infected trachea. A number of
infected deciduous mucosal epithelium cells in the trachea
(arrows). (G) pBJ09 virus-infected trachea. Infected mucosal
epithelium cells in the trachea (arrows). (H) Triple-1222 virus-
infected trachea. Weak viral antigen staining in mucosal
epithelium cells in the trachea (arrows). (I) Eurasian-204
virus-infected trachea. No positive viral antigen staining in
the trachea. (J) hTJ15 virus-infected trachea. Rare viral
antigen staining in the mucosal epithelium cells in the trachea
(arrows). (K) rH1N1 virus-infected nasal turbinate. Infected
mucosal epithelium cells in the nasal turbinates (arrows). (L)
pBJ09 virus-infected nasal turbinate. Infected deciduous
mucosal epithelium cells in the nasal turbinates (arrows). (M)
Triple-1222 virus-infected nasal turbinate. Infected serous
gland epithelium cells in the nasal turbinates (arrows). (N)
Eurasian-204 virus-infected nasal turbinate. Less infected
cells in the lamina propria of the nasal turbinates (arrows). (O)
hTJ15 virus-infected nasal turbinate. Less infected cells in
the lamina propria of the nasal turbinates (arrows). Bar=50 mm.
(TIF)
Table S1 Amino acid differences of the NS1 proteins
between rH1N1 and pBJ09 viruses.
(PDF)
Table S2 Amino acid differences of the NS2 proteins
between rH1N1 and pBJ09 viruses.
(PDF)
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